Cargando…
Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214095/ https://www.ncbi.nlm.nih.gov/pubmed/37218500 http://dx.doi.org/10.1042/BSR-2019-2800_EOC |
Ejemplares similares
-
Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation
por: Lin, Yan, et al.
Publicado: (2020) -
Expression of Concern: LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome formation
Publicado: (2023) -
Expression of Concern: Enterococcus durans TN-3 Induces Regulatory T Cells and Suppresses the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis
Publicado: (2023) -
Expression of concern on ‘COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells’
Publicado: (2022) -
Expression of Concern: MicroRNA-144-3p inhibits High Glucose induced Cell proliferation through Suppressing FGF16
Publicado: (2020)